top of page

Funding deal signed for new food and drug discovery centre at Ulster University Coleraine

Writer: Love Ballymena
Love Ballymena
7 hours ago
3 min read
Deputy Chief Executive of Causeway Coast and Glens Borough Council, Moira Quinn; Ulster University Vice-Chancellor Professor Paul Bartholomew, and Mayor of Causeway Coast and Glens Borough Council, Councillor Dawn Huggins signing the official funding agreement for Ulster University's Coleraine's Centre for Food and Drug Discovery (CFDD),

L-R Deputy Chief Executive of Causeway Coast and Glens Borough Council, Moira Quinn; Ulster University Vice-Chancellor Professor Paul Bartholomew, and Mayor of Causeway Coast and Glens Borough Council, Councillor Dawn Huggins signing the official funding agreement for Ulster University's Coleraine's Centre for Food and Drug Discovery (CFDD),


Saturday 21 November 2026


Plans for a new food and drug discovery centre at Ulster University's Coleraine campus have moved a step closer to delivery following the signing of a funding agreement under the Causeway Coast and Glens Growth Deal.


The Centre for Food and Drug Discovery (CFDD) will bring together university researchers and businesses to develop new medicines, healthier food products and health technologies, with specialist equipment helping companies test and bring their innovations to market.


The agreement marks the project's transition from planning towards delivery, with design and enabling works now set to progress.



Helping businesses turn research into new treatments


The centre will combine expertise in pharmaceutical sciences, biomedical research and food innovation, providing businesses with access to specialist facilities and research support.


Funding will be used to purchase equipment that allows industry partners to develop and test products at different stages, from early research through to commercialisation.


The aim is to help businesses overcome research and development challenges, particularly where they lack the specialist equipment or expertise needed to advance new products themselves.


The project forms part of the wider Causeway Coast and Glens Growth Deal, which is intended to support economic growth, investment and employment opportunities across the borough.



Research already delivering results


Although the centre is moving towards its next phase of development, its researchers have already worked with companies on projects with international commercial applications.


These include clinical trials and regulatory evidence work for Belfast-based health technology company Neurovalens, involving devices designed to address insomnia, anxiety and weight management.


According to Ulster University, the research contributed to evidence supporting approvals from the US Food and Drug Administration (FDA), helping the company access the American market.


The centre has also established a relationship with pharmaceutical company Almac Group and secured an Academy of Medical Sciences grant for collaborative research into new ways of manufacturing medicines that can be more easily absorbed by the body.


The work aims to improve how medicines are delivered and potentially increase their effectiveness for patients.



Investment in skills and high-value employment


Beyond the potential health benefits, the project is expected to support Northern Ireland's growing life and health sciences sector by encouraging business innovation, attracting investment and developing specialist skills.


Ulster University Vice-Chancellor Professor Paul Bartholomew said the centre would help connect scientific research with practical applications.


“The CFDD will help bridge the gap between scientific discovery and real-world application through accelerating innovation, reducing barriers to product development, and supporting the delivery of new solutions that improve public health outcomes.


“This impact will be felt across Northern Ireland by attracting investment, creating high value jobs, and creating opportunities for businesses, researchers and students to contribute to innovations that improve lives.”



Professor Bartholomew said the funding agreement would allow work to progress, turning the project's ambitions for regional growth into practical action.


Growth Deal milestone welcomed


Mayor of Causeway Coast and Glens Borough Council, Councillor Dawn Huggins, welcomed the agreement as an important milestone for the borough.


"By bringing together world-class expertise and industry, this project has the potential to support new discoveries, create opportunities for collaboration and contribute to better health outcomes for people locally and further afield.


“As Mayor, I am delighted to see this investment progressing and look forward to seeing the positive impact it will have on our local economy, our communities and the future of innovation in Causeway Coast and Glens.”



Economy Minister Dr Caoimhe Archibald said the project would give businesses greater access to the facilities and expertise needed to develop new products and compete internationally.


“This project offers a tremendous opportunity to grow the life and health sciences sector. It will provide businesses with access to specialist equipment and research expertise to develop, test and commercialise new products—helping firms overcome barriers to innovation, compete in global markets and pursue new opportunities for growth.


“Building on significant investments already made in the north’s life and health sciences sector, it can help attract further investment and support the creation of high-value jobs.”



Next stage of development at Coleraine


With the funding agreement signed, the project will now move forward with design and enabling works, while the university continues discussions with industry partners about their research and development needs.


The centre is inviting businesses of all sizes, from small and medium-sized enterprises to major corporations, to explore opportunities for collaboration.


Companies interested in accessing specialist research expertise, developing new medicines or food products, or testing health technologies can find further information at https://www.ulster.ac.uk/cfdd⁠.

bottom of page